Regulation of vascular type 1 angiotensin receptors by cytokines

Hypertension

Volumn 30, Issue 1, 1997, Pages 35-41

  Sasamura, Hiroyuki ^a   Nakazato, Yuichi ^a   Hayashida, Tomoko ^a   Kitamura, Yudai ^a   Hayashi, Matsuhiko ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Angiotensin; Cytokines; Interferons; Interleukin 1; Receptors; Tumor necrosis factor

Indexed keywords

ANGIOTENSIN RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; DOWN REGULATION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0030849135     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.1.35     Document Type: Article

References (33)

1. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:745-756.
2. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991;17:626-635.
3. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 1991;9:17-22.
4. Ohishi M, Ueda M, Rakugi H, Higaki J, Kamide K, Naruko T, Becker AE, Ogihara T. Immunocytochemical localization of angiotensin II, ACE, and chymase in human coronary atherosclerotic lesions. J Hypertens. 1996;14(suppl 1):S136. Abstract.
5. Rakugi H, Kim D-K, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury. J Clin Invest. 1994;93:339-346.
6. Prescott MF, Webb RL, Reidy MA. Angiotensin-converting enzyme inhibitor versus angiotensin II AT1 receptor antagonist: effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol. 1991;139:1291-1296.
7. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy. J Clin Invest. 1994;94:978-984.
8. Dzau VJ, Sasamura H, Hein L. Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacologic implications. J Hypertens. 1993;11(suppl 3):S13-S18.
9. Sato A, Suzuki H, Murakami M, Nakazato Y, Iwaita Y, Saruta T. Glucocorticoid increases angiotensin II type 1 receptor and its gene expression. Hypertension. 1994;23:25-30.
10. Sato A, Suzuki H, Iwaita Y, Nakazato Y, Kato H, Saruta T. Potentiation of inositol trisphosphate production by dexamethasone. Hypertension. 1992;19:109-115.
11. Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, Senba S. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. J Clin Endocrinol Metab. 1986;62:275-279.
12. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
13. Bourcier T, Dockter M, Hassid A. Synergistic interaction of interleukin-1beta and growth factors in primary cultures of rat aortic smooth muscle cells. J Cell Physiol. 1995;164:644-657.
14. Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978;87: 206-210.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
16. Iwai N, Inagami T. Identification of two subtypes in the rat type 1 angiotensin II receptor. FEBS Lett. 1992;298:257-260.
17. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic peptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990;86: 1690-1697.
18. Moyer CF, Sajuthi D, Tulli H, Williams JK. Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol. 1991;138:951-960.
19. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 1990;65:297-302.
20. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol. 1989; 135:169-175.
21. Libby P, Warner SJC, Friedman GB. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest. 1988;81:487-498.
22. Raines EW, Dower SK, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science. 1989;243:393-396.
23. Fujitani Y, Ninomiya H, Okada T, Urade Y, Masaki T. Suppression of endothelin 1-induced mitogenic responses of human aortic smooth muscle cells by interleukin-1beta. J Clin Invest. 1995;95: 2474-2482.
24. Ullian ME, Linas SL. Angiotensin II surface receptor coupling to inositol trisphosphate formation in vascular smooth muscle cells. J Biol Chem. 1990;265:195-200.
25. Bomsztyk K, Rooney JW, Iwasaki T, Rachie NA, Dower SK, Hopkins-Sibley C. Evidence that interleukin-1 and phorbol esters activate NF-κB by different pathways: role of protein kinase C. Cell Regul. 1991;2:329-335.
26. Inagami T, Guo D-F, Kitami Y. Molecular biology of angiotensin II receptors: an overview. J Hypertens. 1994;12(suppl 10):S83-S94.
27. Ichiki T, Kambayashi Y, Inagami T. Multiple growth factors modulate mRNA expression of angiotensin II type-2 receptor in R3T3 cells. Circ Res. 1995;77:1070-1076.
28. Sedor JR, Nakazato Y, Konieczkowski M. Interleukin-1 and the mesangial cell. Kidney Int. 1992;41:595-599.
29. Palmer JN, Hartogensis WE, Patten M, Fortuin FD, Long CS. Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest. 1995;95: 2555-2564.
30. Brock TA, Rittenhouse SE, Powers CW, Ekstein LS, Gimbrone MA, Alexander RW. Phorbol ester and 1-oleoyl-2-acetylglycerol inhibit angiotensin activation of phospholipase C in cultured vascular smooth muscle cells. J Biol Chem. 1985;260:14158-14162.
31. Marumo T, Nakaki T, Nagata K, Miyata M, Adachi H, Esumi H, Suzuki H, Saruta T, Kato R. Dexamethasone inhibits nitric oxide synthase mRNA induction by interleukin-lalpha and tumor necrosis factor-alpha in vascular smooth muscle cells. Jpn J Pharmacol. 1993;63:361-367.
32. Cahill PA, Redmond EM, Foster C, Sitzmann JV. Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cells. Eur J Pharmacol. 1995;288:219-229.
33. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Foerstermann U. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol. 1996;49:15-21.